AI equity research tools, platforms and agents, and what AI investment research still gets wrong
Every AI research platform makes the same promise: read everything, summarize it, and hand you the thesis. The promise is largely real. The part nobody sells you is the checking step, and two 2026 studies of live analyst output disagree sharply about whether AI-assisted research is more accurate or less.
- 1 THESIS
- 2 EVIDENCE
- 3 BACKTEST
- 4 RISK
- 5 VERDICT
02 EVIDENCE · FUNDAMENTALS
04 RISK · IN PLAIN ENGLISH
Sample scenarios, not a live backtest of what you typed. Past performance does not guarantee future results. Educational analysis only, not financial advice.
In short
AI equity research means using language models to read filings, transcripts and market history and produce the summaries, comparisons and drafts an analyst used to assemble by hand, and the category splits cleanly into two price tiers. At the institutional end, AlphaSense, Hebbia and Rogo sell seat-licensed enterprise platforms with no public price list, built around document corpora, data-room reasoning and standardized banking outputs such as comparable company analyses and company profiles. At the accessible end sit data terminals like Koyfin, from free to $299 per month as of August 2026, and general assistants like ChatGPT at $20 per month, which explain well and have no price database behind them. The evidence on whether any of this makes research better is genuinely split. Xue, Zhang and Zhu, studying FactSet's 2023 AI platform launch as a natural experiment in "Generative AI for Analysts" (arXiv 2512.19705, December 2025), found AI-assisted reports carried 40% more distinct information sources, 34% broader topical coverage and 25% greater use of advanced analytical methods, while forecast errors rose 59%. Huang, Hugon, Zhang and Zheng, in "Generative AI and Investment Research: Evidence from Analyst Reports" (SSRN 6682498, January 2026), found the opposite on accuracy: AI-assisted reports showed greater earnings forecast accuracy, most of all for analysts under heavy workload or with lower baseline skill. Both can be true, because they measure different adoption patterns, and both point at the same missing step. AgentTrading covers that step and nothing else: state the testable claim inside your thesis in one sentence, confirm the rule the bench extracted, and run it across 20+ years of split- and dividend-adjusted daily data with 0.1% charged per trade, stamped HELD UP, MIXED or UNDERPERFORMED against buy and hold over identical dates. It is not a filings corpus, it does not build comps or models, and it does not write your report. It answers whether the idea in the report survived the record, from $19 per month. Educational analysis only, no execution, no personalized advice, and past performance does not guarantee future results.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.
SIDE BY SIDE - PRICING CHECKED AUGUST 2026
AI equity research platforms, side by side
Two tiers, and the gap between them is wider than any feature list suggests. The enterprise platforms publish no prices at all, which is itself the most useful thing to know before you start a procurement process. Read the last column twice: every tool here is good at something, and every one of them has a boundary its own marketing skips.
| Tool | Best for | Price (August 2026) | The honest limitation |
|---|---|---|---|
| AgentTrading | Testing the claim inside a research thesis against the record | From $19/mo | No filings corpus, no comps, no model builder, no report drafting. Daily bars, US equities and ETFs. |
| AlphaSense | Institutional search across filings, transcripts and broker research | Enterprise seat licence, no public price list | Priced and provisioned for institutions, and there is no backtesting engine behind the search. |
| Hebbia | Running the same question across hundreds of documents at once | Enterprise, contact sales | Document reasoning, not market data. Nothing here tests a thesis against price history. |
| Rogo | Standardized sell-side outputs: comps, profiles, pitch materials | Enterprise, contact sales | Shaped around investment banking deal workflows rather than a buy-side or RIA research process. |
| Koyfin | A data and charting terminal at a price a person can pay | Free; $39 to $299/mo | Gives you the data and the charts. The analysis, and the testing, are still yours to do. |
| ChatGPT | Explaining concepts and drafting prose around research you already have | $20/mo | No price database and no backtesting engine. Asked for historical figures, it will produce invented ones. |
Prices are the vendors' public list prices, checked August 2026, and vendors change them. Verify current pricing and capabilities with each vendor before you buy.
AgentTrading
Testing the claim inside a research thesis against the record
This is deliberately one station rather than a research suite. You state the testable claim in a sentence, confirm the rule card the bench extracted so you know exactly what will run, and watch it execute across 20+ years of split- and dividend-adjusted daily data with 0.1% charged per trade, stamped against buy and hold over identical dates. If you need a document corpus, a comparable company analysis, or a drafted report, buy one of the platforms below instead. If what you need is to find out whether the idea your research just produced has ever worked, that is the whole job here, and the answer is allowed to be no.
AlphaSense
Institutional search across filings, transcripts and broker research
The deepest content corpus in the category, covering company filings, earnings call transcripts, expert call libraries and licensed broker research, with AI search and summarization over the top. If your problem is that the answer exists somewhere across thousands of documents and you cannot find it, this is the category leader. Two practical notes: pricing is quoted per seat through a sales process rather than published, so budget for a procurement cycle, and everything it does is retrieval and synthesis. It will find you the analyst who made your argument in 2023. It will not tell you whether the argument held up.
Hebbia
Running the same question across hundreds of documents at once
Hebbia's Matrix workspace is built for the grid-shaped problem specific to deal teams and asset managers: many documents down one axis, many questions across the other, every cell answered with a citation back to the source and the whole thing exportable. Applied to data rooms, information memoranda, transcripts and SEC filings, it is a genuine step beyond chat-with-your-PDF, and the citation trail is what makes the output defensible. Same boundary as the rest of this tier: it reasons over what the documents say, and it has no view on what the market subsequently did.
Rogo
Standardized sell-side outputs: comps, profiles, pitch materials
Founded in 2021 by former investment bankers and pointed squarely at the work junior bankers do: comparable company analyses, company profiles, industry overviews, information memoranda and pitch preparation. If your output is a banker deliverable in a house format, this is the tool built for that shape of work. If your output is an investment decision you have to live with, the fit is looser, because the deliverables it automates are the presentation layer rather than the judgment underneath.
Koyfin
A data and charting terminal at a price a person can pay
The most credible answer for anyone who wants Bloomberg-shaped functionality without a Bloomberg budget: financials, estimates, dashboards, screening and charting, free at the bottom and $39 for Plus, $79 for Premium, $209 for Advisor Core and $299 per month for Advisor Pro when checked on August 4, 2026. It is a terminal rather than an AI research platform, which is a feature if you distrust generated conclusions. The gap it leaves is the one this whole page is about: excellent data does not tell you whether the rule you inferred from it ever worked.
ChatGPT
Explaining concepts and drafting prose around research you already have
A patient tutor and a fast drafter, and for learning what a metric means or restructuring an argument it is genuinely excellent value at $20 per month. The failure mode is specific and worth stating plainly, because it catches experienced people: ask what a strategy returned since 2010 and you will get a confident, precise, fabricated number, because there is no market data source underneath the answer. Use it for reasoning and language. Do not use it as a source of evidence, and check every figure it hands you against something that actually holds the data.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.
WHAT YOU GET - AI EQUITY RESEARCH
AI equity research, run on the bench
The checking step the research platforms leave out
Enterprise platforms are retrieval and synthesis engines: they find what was written and summarize it well. None of them answers whether the conclusion held up. That question needs price history, a stated rule and costs charged, which is the one thing this bench does and the reason it sits alongside a research platform rather than competing with it.
A rule card you confirm before anything runs
The most common failure in AI-assisted research is not a wrong answer, it is a right answer to a question you did not ask. The bench prints the explicit entry, exit and universe it extracted from your sentence, and you confirm it before the run. Catching a misread costs five seconds here and considerably more after you have written it into a memo.
Every assumption logged, so the work is defensible later
Date range, parameters, the 0.1% charged per trade, the trade count and the comparison window are all recorded with the result. When someone senior asks in three months why you concluded what you concluded, the answer is a record rather than a recollection. That audit trail is what separates research from an opinion with numbers attached.
A verdict that is allowed to say no
The output is HELD UP, MIXED or UNDERPERFORMED against buy and hold over identical dates, and UNDERPERFORMED appears often because most attractive-sounding rules do not beat simply owning the thing. A research tool that never contradicts you is not saving you work, it is agreeing with you faster.
HOW IT WORKS - 4 STEPS
From a sentence to a stamped verdict
Do the research wherever you already do it
Filings, transcripts, a terminal, an AI platform, your own notes. This bench does not replace that step and does not want to. Come out of it with a thesis you could state to a colleague in one sentence.
Isolate the testable claim inside the thesis
Most theses contain one. "Quality compounders outperform after a market drawdown" contains a rule. "This company is well managed" does not. Name the instrument, the entry condition, the exit condition and where cash sits in between.
Confirm the rule card, then run it on 20+ years
Split- and dividend-adjusted daily data, dividends reinvested, 0.1% charged per trade, and the deepest drawdown window shaded on the equity curve so the worst stretch is visible rather than averaged into a summary statistic.
Read the verdict, the trade count, then the drawdown
HELD UP, MIXED or UNDERPERFORMED against buy and hold for identical dates, with CAGR, maximum drawdown, Sharpe ratio and trade count side by side. A result built on eleven trades in twenty years is a coincidence with a chart, and the trade count says so.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.
On the same bench
Equity research is the professional vocabulary for the same loop the rest of the bench serves: AI stock research is the retail-facing version that takes a thesis from evidence to verdict, AI stock analysis is the evidence station, and the fundamental analysis tool goes deeper on filings. Teams that need one auditable process across several analysts should read equity research tools for teams; the adviser and club views are on tools for financial advisors and investment club research tools. On the testing side, the mechanics of stating a claim are on the trading strategy tester, a single name goes through stock backtesting, and what feeds every run is on historical stock data. If you are pricing the alternatives first, the honest write-ups are the Koyfin alternative, the Seeking Alpha alternative, the ChatGPT stock analysis comparison, and the roundup on best AI trading software. The evidence on whether AI is taking this job is set out in will AI replace equity research analysts, and the workflow itself in how to analyze a stock. Plans start at $19 a month.
QUESTIONS - ASKED AND ANSWERED
AI equity research: the common questions
What is AI equity research?
AI equity research is the use of language models to do the reading and assembly work inside a research process: pulling figures out of filings, summarizing earnings calls, comparing a company against its peers, and drafting the narrative around a thesis. The useful distinction is between retrieval tools, which find and summarize what already exists, and testing tools, which check a claim against historical data. Most of the market sells the first kind, and almost every research failure comes from skipping the second.
Will AI replace equity research analysts?
The current evidence says the job is being reshaped rather than removed, and the two most recent studies disagree about whether the reshaping helps. Xue, Zhang and Zhu found reports got broader and timelier while forecast errors rose 59% after FactSet's AI platform launched. Huang, Hugon, Zhang and Zheng found the opposite on accuracy, with the gain concentrated among analysts under heavy workload. What both describe is a job where the assembly work compresses and the judgment work becomes the whole value.
What is the best AI for equity research?
It depends on which part of the job you are hiring it for. For institutional search across filings, transcripts and broker research, AlphaSense has the deepest corpus. For running one question across hundreds of documents with citations, Hebbia. For standardized sell-side deliverables such as comps and company profiles, Rogo. For data and charting at an individual price, Koyfin from free to $299 per month. For checking whether the claim inside the research survived twenty years of prices and costs, that is what AgentTrading does from $19 per month. None of these is a substitute for another.
Can AI write an equity research report?
It can write a competent draft, and that is now routine rather than notable. What it cannot do is take responsibility for the numbers in it. The reported effect on quality is mixed in the literature: AI-assisted reports measurably cover more ground, with 40% more distinct information sources and 34% broader topical coverage in the FactSet study, and the same study found forecast errors rose 59%, which the authors attribute to a more balanced mix of positive and negative information being harder to synthesize. Treat generated reports as drafts with an unverified evidence base.
How much do AI equity research platforms cost?
The enterprise tier does not publish prices. AlphaSense, Hebbia and Rogo all quote per seat through a sales process, so the honest answer is that you will find out during procurement rather than on a pricing page, and third-party contract data points at four to five figures per seat per year. The accessible tier does publish: Koyfin runs free to $299 per month, ChatGPT is $20 per month, and AgentTrading starts at $19 per month. If a vendor will not show you a price, that is a signal about who the product is built for, not a trick.
What is an AI equity research agent?
An agent, in this context, is a system that runs a multi-step research task without being prompted at each step: read this filing, extract these line items, compare them against the peer set, flag what changed, draft the summary. It is a genuine advance over single-turn chat for repetitive assembly work. The caution is that longer autonomous chains make errors harder to spot, because the mistake happens in step three and you only ever see step seven. Agents that cite their sources at each step are meaningfully safer than agents that hand you a conclusion.
Is AI-generated equity research accurate?
Accurate at reading, unreliable at predicting, and highly variable at reporting numbers. Models are strong at summarizing a document, comparing figures across periods and explaining what a ratio means, because those tasks have a source to check against. They are weak at forecasting, and a general assistant with no market data behind it will produce fabricated historical figures with complete confidence. The working rule is to trust the reading, verify every number, and test every claim that can be tested.
Can AI do investment research on its own?
It can do the assembly on its own and it cannot do the deciding. The parts that automate well are exactly the parts that are mechanical: locating disclosures, normalizing figures, building the peer comparison, summarizing what management said and how it differed from last quarter. What does not automate is deciding which of those facts matters, what the market has already priced, and whether you would still hold the position through a 40% drawdown. Those are judgment calls, and no current system makes them for you.
What AI tools do equity research analysts use?
In practice, a stack rather than a single product. Most institutional teams pair a document platform such as AlphaSense or Hebbia with the data terminal they already run, then use a general assistant for drafting and explanation, and keep their models in spreadsheets. The consistent gap across every stack we have looked at is verification: almost nothing in the standard toolkit tests whether a stated claim held up historically.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.
Your next idea deserves a verdict, not a hunch.
Bring a thesis or a ticker. AgentTrading restates the rule, shows the evidence, runs 20+ years of history, and stamps an honest verdict. You decide.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.